Induction of genome instability by DNA damage in Saccharomyces cerevisiae

DNA Repair

Volumn 2, Issue 3, 2003, Pages 243-258

  Myung, Kyungjae ^a,b   Kolodner, Richard D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Cancer; DNA damage; Double strand breaks; Gross chromosomal rearrangement; HO endonuclease; MMS

Indexed keywords

BLEOMYCIN; CAMPTOTHECAN; CISPLATIN; DNA; DOUBLE STRANDED DNA; ENDONUCLEASE; MESYLIC ACID ETHYL ESTER; MESYLIC ACID METHYL ESTER; METHYLNITRONITROSOGUANIDINE; MUTAGENIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME DELETION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; GAMMA RADIATION; GENE INDUCTION; GENETIC ANALYSIS; GENETIC STABILITY; GENOME; MUTAGEN TESTING; MUTAGENICITY; MUTANT; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE; TELOMERE;

CHROMOSOME ABERRATIONS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA DAMAGE; DNA LIGASES; GENOME, FUNGAL; METHYL METHANESULFONATE; MUTAGENS; SACCHAROMYCES CEREVISIAE; TELOMERASE;

SACCHAROMYCES; SACCHAROMYCES CEREVISIAE;

EID: 0037356692     PISSN: 15687864     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-7864(02)00216-1     Document Type: Article

References (71)

1. Kinzler K.W., Vogelstein B. Landscaping the cancer terrain. Science. 280:1998;1036-1037.
2. Vessey C.J., Norbury C.J., Hickson I.D. Genetic disorders associated with cancer predisposition and genomic instability. Prog. Nucleic Acid Res. Mol. Biol. 63:1999;189-221.
3. Coleman W.B., Tsongalis G.J. The role of genomic instability in human carcinogenesis. Anticancer Res. 19:1999;4645-4664.
4. Kolodner R.D., Putnam C.D., Myung K. Maintenance of genome stability in Saccharomyces cerevisiae. Science. 297:2002;552-557.
5. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev. 10:1996;1433-1442.
6. Lengauer C., Kinzler K.W., Voelstein B. Genetic instabilities in human cancers. Nature. 396:1998;643-649.
7. Loeb L.A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 51:1991;3075-3079.
8. Kolodner R.D., Marsischky G.T. Eukaryotic DNA mismatch repair. Curr. Opin. Genet. Dev. 9:1999;89-96.
9. Jacob S., Praz F. DNA mismatch repair defects: role in colorectal carcinogenesis. Biochimie. 84:2002;27-47.
10. Khanna K.K., Jackson S.P. DNA double-strand breaks: signaling, repair and the cancer connection. Nat. Genet. 27:2001;247-254.
11. Savitsky K.et al. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
12. Moynahan M.E., Pierce A.J., Jasin M. BRCA2 is required for homology-directed repair of chromosomal breaks. Mol. Cell. 7:2001;263-272.
13. Stewart G.S.et al. The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia telangiectasia-like disorder. Cell. 99:1999;577-587.
14. Bell D.W.et al. Heterozygous germ line hCHK2 mutations in Li-Fraumini syndrome. Science. 186:1999;2528-2531.
15. Carney J.P.et al. The hMRE11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response. Cell. 93:1998;477-486.
16. Petrini J.H.J. The Mre11 complex and ATM: collaborating to navigate S-phase. Curr. Opin. Cell Biol. 12:2000;293-296.
17. Gatei M.et al. ATM-dependent phosphorylation of nibrin in response to radiation exposure. Nat. Genet. 25:2000;115-119.
18. Wu X.et al. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response. Nature. 405:2000;477-482.
19. Zhong Q.et al. Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response. Science. 285:1999;747-750.
20. Cortez D., Wang Y., Qin J., Elledge S.J. Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks. Science. 286:1999;1162-1166.
21. Chen C., Kolodner R.D. Gross chromosomal rearrangements in Saccharomyces cerevisiae replication and recombination defective mutants. Nat. Genet. 23:1999;81-85.
22. Myung K., Datta A., Chen C., Kolodner R.D. SGS1, the Saccharomyces cerevisiae homologue of BLM and WRN, functions in the suppression of genome instability and homeologous recombination. Nat. Genet. 27:2001;113-116.
23. Myung K., Datta A., Kolodner R.D. Suppression of spontaneous chromosomal rearrangements by the S-phase checkpoint in Saccharomyces cerevisiae. Cell. 104:2001;397-408.
24. Myung K., Chen C., Kolodner R.D. Multiple pathways cooperate in the suppression of genome instability in Saccharomyces cerevisiae. Nature. 411:2001;1073-1076.
25. Myung K., Kolodner R.D. Suppression of genome instability by redundant S-phase checkpoint pathways in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U.S.A. 99:2002;4500-4507.
26. Haber J.E. Lucky breaks: analysis of recombination in Saccharomyces. Mutat. Res. 451:2000;53-69.
27. Fasullo M., Giallanza P., Dong Z., Cera C., Bennett T. Saccharomyces cerevisiae rad51 mutants are defective in DNA damage-associated sister chromatid exchanges but exhibit increased rates of homology-directed translocations. Genetics. 158:2001;959-972.
28. Connolly B., White C.I., Haber J.E. Physical monitoring of mating type switching in Saccharomyces cerevisiae. Mol. Cell. Biol. 8:1988;2342-2349.
29. Nickoloff J.A., Singer J.D., Hoekstra M.F., Heffron F. Double-strand breaks stimulate alternative mechanisms of recombination repair. J. Mol. Biol. 207:1989;527-541.
30. Raveh D., Hughes S.H., Shafer B.K., Strathern J.N. Analysis of the HO-cleaved MAT DNA intermediate generated during the mating type switch in the yeast Saccharomyces cerevisiae. Mol. Gen. Genet. 220:1989;33-42.
31. Rudin N., Haber J.E. Efficient repair of HO-induced chromosomal breaks in Saccharomyces cerevisiae by recombination between flanking homologous sequences. Mol. Cell. Biol. 8:1988;3918-3928.
32. Rudin N., Sugarman E., Haber J.E. Genetic and physical analysis of double-strand break repair and recombination in Saccharomyces cerevisiae. Genetics. 122:1989;519-534.
33. White C.I., Haber J.E. Intermediates of recombination during mating type switching in Saccharomyces cerevisiae. EMBO J. 9:1990;663-673.
34. Teng S.C., Kim B., Gabriel A. Retrotransposon reverse-transcriptase-mediated repair of chromosomal breaks. Nature. 383:1996;641-644.
35. Tsukamoto Y., Kato J., Ikeda H. Effects of mutations of RAD50, RAD51, RAD52 and related genes on illegitimate recombination in Saccharomyces cerevisiae. Genetics. 142:1996;383-391.
36. Moore J.K., Haber J.E. Cell cycle and genetic requirements of two pathways of nonhomologous end-joining repair of double-strand breaks in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:1996;2164-2173.
37. Moore J.K., Haber J.E. Capture of retrotransposon DNA at the sites of chromosomal double-strand breaks. Nature. 383:1996;644-646.
38. Kramer K.M., Brock J.A., Bloom K., Moore J.K., Haber J.E. Two different types of double-strand breaks in Saccharomyces cerevisiae are repaired by similar RAD52-independent, nonhomologous recombination events. Mol. Cell. Biol. 14:1994;1293-1301.
39. Bosco G., Haber J.E. Chromosome break-induced DNA replication leads to nonreciprocal translocations and telomere capture. Genetics. 150:1998;1037-1047.
40. Lee S.E., Moore J.K., Holmes A., Umezu K., Kolodner R.D., Haber J.E. Saccharomyces Ku70, Mre11/Rad50 and RPA proteins regulate adaptation to G2/M arrest after DNA damage. Cell. 94:1998;399-409.
41. Boulton S.J., Jackson S.P. Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J. 17:1998;1819-1828.
42. Lingner J., Hughes T.R., Shevchenko A., Mann M., Lundblad V., Cech T.R. Reverse transcriptase motifs in the catalytic subunit of telomerase. Science. 276:1997;561-567.
43. Zhou J.-Q., Monson E.K., Teng S.-C., Schulz V.P., Zakian V.A. Pif1p helicase, a catalytic inhibitor of telomerase in yeast. Science. 289:2000;771-774.
44. Rizki A., Lundblad V. Defects in mismatch repair promote telomerase-independent proliferation. Nature. 411:2001;713-716.
45. Paulovich A.G., Margulies R.U., Garvik B.M., Hartwell L.H. RAD9, RAD17 and RAD24 are required for S-phase regulation in Saccharomyces cerevisiae in response to DNA damage. Genetics. 145:1997;45-62.
46. Frei C., Gasser S.M. The yeast Sgs1p helicase acts upstream of Rad53p in the DNA replication checkpoint and colocalizes with Rad53p in S-phase-specific foci. Genes Dev. 14:2000;81-96.
47. Gilbert C.S., Green C.M., Lowndes N.F. Budding yeast Rad9 is an ATP-dependent Rad53 activating machine. Mol. Cell. 8:2001;129-136.
48. Usui T., Ogawa H., Petrini J.H.J. A DNA damage response pathway controlled by Tel1 and the Mre11 complex. Mol. Cell. 7:2001;1255-1266.
49. Haber J. The many interfaces of Mre11. Cell. 95:1998;583-586.
50. Teo S.H., Jackson S.P. Identification of Saccharomyces cerevisiae DNA ligase IV: involvement in DNA double-strand break-repair. EMBO J. 16:1997;4788-4795.
51. Milne G.T., Jin S., Shannon K.B., Weaver D.T. Mutations in two Ku homologs define a DNA end-joining repair pathway in Saccharomyces cerevisiae. Mol. Cell. Biol. 16:1996;4189-4198.
52. Malkova A., Ivanov E.L., Haber J.E. Double-strand break repair in the absence of RAD51 in yeast: a possible role for break-induced DNA replication. Proc. Natl. Acad. Sci. U.S.A. 93:1996;7131-7136.
53. Signon L., Malkova A., Naylor M.L., Klein H., Haber J.E. Genetic requirements for RAD51- and RAD54-independent break-induced replication repair of a chromosomal double-strand break. Mol. Cell. Biol. 21:2001;2048-2056.
54. Malkova A., Signon L., Schaefer C.B., Naylor M.L., Theis J.F., Newlon C.S., Haber J.E. RAD51-independent break-induced replication to repair a broken chromosome depends on a distant enhancer site. Genes Dev. 15:2001;1055-1060.
55. Chen C., Umezu K., Kolodner R.D. Chromosomal rearrangements occur in S. cerevisiae rfa1 mutator mutants due to mutagenic lesions processed by double-strand-break repair. Mol. Cell. 2:1998;9-22.
56. P.D. Lawley, Approaches to chemical dosimetry in mutagenesis and carcinogenesis: the relevance of reactions of chemical mutagens and carcinogens in DNA, in: P.L. Grover (Ed.), Chemical Carcinogens and DNA, CRC Press, Boca Raton, FL, 1979, pp. 1-79.
57. Sega G.A. A review of the genetic effects of ethyl methane sulfonate. Mutat. Res. 134:1984;113-142.
58. E.C. Friedberg, G.C. Walker, W. Siede, DNA Repair and Mutagenesis. ASM Press, Washington, DC, 1995.
59. Foiani M., Pellicioli A., Lepes M., Lucca C., Ferrari M., Liberi G., Muzi Falconi M., Plevani P. DNA damage checkpoints and DNA replication controls in Saccharomyces cerevisiae. Mutat. Res. 451:2000;187-196.
60. Lewis L.K., Resnick M.A. Tying up loose ends: nonhomologous end-joining in Saccharomyces cerevisiae. Mutat. Res. 451:2000;71-89.
61. Diede S.J., Gottschling D.E. Telomerase-mediated telomere addition in vivo requires DNA primase and DNA polymerases α and δ Cell. 99:1999;723-733.
62. Nickolff J.A., Chen E.Y., Heffron F. A 24-base-pair DNA sequence from the MAT locus stimulates intergenic recombination in yeast. Proc. Natl. Acad. Sci. U.S.A. 83:1986;7831-7835.
63. Jiricny J. Replication errors: cha(lle)nging the genome. EMBO J. 17:1998;6427-6436.
64. Murray V. A survey of the sequence-specific interaction of damaging agents with DNA: emphasis on antitumor agents. Prog. Nucleic Acid Res. Mol. Biol. 63:1999;367-415.
65. Hagan C.R., Rudin C.M. Mobile genetic element activation and genotoxic cancer therapy: potential clinical implications. Am. J. Pharmacogenom. 2:2002;25-35.
66. Knutsen T. Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL. Genes Chromosomes Cancer. 23:1998;44-54.
67. Felix C.A. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol. 36:2001;525-535.
68. Lopes L.F., Neto E.D., Lorand-Metze I., Latorre M.R., Simpson A.J. Analysis of Vγ/Jβ trans-rearrangements in paediatric patients undergoing chemotherapy. Br. J. Haematol. 113:2001;1001-1008.
69. Fukuda N., Shinohara K., Ota I., Muraki K., Shimohakamada Y. Therapy-related myelodysplastic syndrome in a case of cutaneous adult T-cell lymphoma. Int. J. Hematol. 75:2002;67-71.
70. Mandelli F., Avvisati G., Lo Coco F. Advances in the understanding and management of acute promyelocytic leukemia. Rev. Clin. Exp. Hematol. 6:2002;60-71.
71. Cohen S.M., Lippard S.J. Cisplatin: from DNA damage to cancer chemotherapy. Prog. Nucleic Acid Res. Mol. Biol. 67:2001;93-130.